公开(公告)号：US09968123B2

公开(公告)日：2018-05-15

申请号：US15128537

申请日：2015-03-23

申请人： ABBOTT LABORATORIES

发明人： Rockendra Gupta ,  Gaurav Patel ,  Normanella Dewille

IPC分类号： A23L1/304 ,  A23L33/21 ,  A23L33/00 ,  A23L33/12 ,  A23L33/15 ,  A23L33/16 ,  A23L33/17 ,  A23L33/18 ,  A23L33/19

CPC分类号： A23L33/21 ,  A23L33/12 ,  A23L33/15 ,  A23L33/16 ,  A23L33/17 ,  A23L33/18 ,  A23L33/19 ,  A23L33/40 ,  A23V2002/00

摘要： A nutritional supplement powder and method of supplementing the nutritional value of a food or beverage is provided. The nutritional supplement powder includes a protein system, vitamins, minerals, and fiber. The protein system has a water solubility of at least about 70% at room temperature. The nutritional supplement powder is essentially free of divalent ions of copper, iron, and zinc, and is also essentially free of vitamin C. When added to a food or beverage, the nutritional supplement powder does not substantially change the organoleptic properties of the food or beverage.

公开(公告)号：US20170246231A9

公开(公告)日：2017-08-31

申请号：US14598632

申请日：2015-01-16

申请人： Lisa Geng

发明人： Lisa Geng

IPC分类号： A61K36/185 ,  A61K36/328 ,  A61K36/9066 ,  A61K36/82 ,  A61K36/54 ,  A61K36/81 ,  A23L1/30 ,  A23L1/302 ,  A23L1/303 ,  A23L1/304 ,  A23L1/305 ,  A23L1/308 ,  A23L1/234 ,  A23L1/226 ,  A61K36/27

CPC分类号： A61K36/185 ,  A23L27/10 ,  A23L27/12 ,  A23L33/105 ,  A23L33/12 ,  A23L33/30 ,  A23V2002/00 ,  A61K36/27 ,  A61K36/328 ,  A61K36/54 ,  A61K36/81 ,  A61K36/82 ,  A61K36/9066 ,  A61K2300/00 ,  A23V2200/322 ,  A23V2250/21

摘要： Nutrient compositions comprising botanical extracts and an omega 3 fatty acid as well as methods of their use for treating, inter alia, autism or apraxia and/or ameliorating one or more symptoms thereof are disclosed. The use of such compositions for enhancing cognitive function and/or one or more aspects thereof, or for treating stroke or seizures and/or ameliorating one or more symptoms thereof are also disclosed.

公开(公告)号：US09505664B2

公开(公告)日：2016-11-29

申请号：US14434071

申请日：2013-09-18

申请人： PRAYON

发明人： Philippe Jacques Myriam Cappelle ,  Kurt Thierry S. Verhelst

IPC分类号： C05B13/06 ,  C05B17/00 ,  C05B17/02 ,  C05G3/00 ,  A23L33/16 ,  A23L33/165 ,  A23L1/304

CPC分类号： C05B13/06 ,  A23K20/26 ,  A23K20/30 ,  A23L33/16 ,  A23L33/165 ,  C05B13/00 ,  C05B13/04 ,  C05B17/00 ,  C05B17/02 ,  C05G3/0076 ,  C05D9/02

摘要： The present invention relates to an inorganic liquid nutritive composition comprising at least one aqueous phase, a polyphosphate and at least one source of iron as micronutrient, having a Ppoly/Fetotal molar ratio of between 5 and 50.

摘要翻译： 本发明涉及无机液体营养组合物，其包含至少一种水相，多磷酸盐和至少一种作为微量营养素的铁源，其Ppoly / Fetotal摩尔比为5至50。

公开(公告)号：US09463176B2

公开(公告)日：2016-10-11

申请号：US13294587

申请日：2011-11-11

申请人： Robert J. J. Hageman

发明人： Robert J. J. Hageman

IPC分类号： A61K33/24 ,  A61K31/202 ,  A23L1/29 ,  A23L1/30 ,  A23L1/302 ,  A23L1/304 ,  A23L1/305 ,  A61K31/185 ,  A61K31/198 ,  A61K31/20 ,  A61K33/32 ,  A61K35/20 ,  A61K45/06

CPC分类号： A61K31/202 ,  A23L33/12 ,  A23L33/15 ,  A23L33/16 ,  A23L33/17 ,  A23L33/40 ,  A23V2002/00 ,  A61K31/185 ,  A61K31/198 ,  A61K31/20 ,  A61K33/24 ,  A61K33/32 ,  A61K35/20 ,  A61K45/06 ,  A61K2300/00 ,  A23V2250/161 ,  A23V2250/1608 ,  A23V2250/302 ,  A23V2250/28 ,  A23V2250/70 ,  A23V2250/72 ,  A23V2250/705 ,  A23V2250/54252 ,  A23V2250/54246 ,  A23V2250/194 ,  A23V2200/332 ,  A23V2250/5488 ,  A23V2250/061 ,  A23V2250/0624 ,  A23V2250/1868 ,  A23V2250/187 ,  A23V2250/0616 ,  A23V2250/1618 ,  A23V2250/7052 ,  A23V2250/7056 ,  A23V2250/706 ,  A23V2250/1612 ,  A23V2250/5114 ,  A23V2250/628 ,  A23V2250/712 ,  A23V2250/708 ,  A23V2250/1626 ,  A23V2250/1642 ,  A23V2250/714 ,  A23V2200/328 ,  A23V2250/548 ,  A23V2250/608 ,  A23V2250/62 ,  A23V2250/5118 ,  A23V2250/5108 ,  A23V2250/218 ,  A23V2250/156 ,  A23V2200/304 ,  A23V2250/0644 ,  A23V2250/304 ,  A23V2250/1842

摘要： It has now been found that after administration to a diseased person or person that is at risk for developing such disease of a neutraceutical or pharmaceutical composition that comprises a) a lipid fraction comprising at least one of docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and eicosapentaenoic acid (EPA); b) a protein fraction comprising proteinaceous material from non-human origin which provide at least cysteine and/or taurine; and c) a mineral fraction comprising at least one of manganese and molybdenum, the health of these persons improves. Membrane function of several types of mammalian cells improves, which allows efficient treatment of immune related disorders, such as allergy, autoimmune diseases, cancer, cognitive dysfunction and other diseases of the nervous system, neuropathies, such as diabetic neuropathies and neuropathic pains, neuronal damage during insulin resistance, and gut diseases and support of the development of gut and lung function during growth or recovery.

公开(公告)号：US09463167B2

公开(公告)日：2016-10-11

申请号：US14618252

申请日：2015-02-10

申请人： Howard Foundation Holdings Limited

发明人： John Nolan ,  Stephen Beatty ,  James Loughman ,  Alan N. Howard ,  David Thurnham

IPC分类号： A61K31/047 ,  A61K31/07 ,  A23L1/30 ,  A23L1/302 ,  A23L1/304 ,  A23L1/32 ,  A61K45/06 ,  A61K35/57 ,  A61K9/48 ,  A61K31/202

CPC分类号： A61K31/047 ,  A23K20/105 ,  A23K20/179 ,  A23K50/75 ,  A23L15/00 ,  A23L15/30 ,  A23L29/256 ,  A23L33/10 ,  A23L33/105 ,  A23L33/115 ,  A23L33/15 ,  A23L33/16 ,  A23V2002/00 ,  A23V2200/00 ,  A61K9/48 ,  A61K31/07 ,  A61K31/202 ,  A61K35/57 ,  A61K35/60 ,  A61K45/06 ,  A23V2200/30 ,  A61K2300/00 ,  A23V2250/00 ,  A23V2250/211 ,  A23V2250/1578 ,  A23V2250/1586 ,  A23V2250/1588 ,  A23V2250/1592 ,  A23V2250/1598 ,  A23V2250/1608 ,  A23V2250/161 ,  A23V2250/1612 ,  A23V2250/1626 ,  A23V2250/1642 ,  A23V2250/702 ,  A23V2250/704 ,  A23V2250/708 ,  A23V2250/71 ,  A23V2250/712 ,  A23V2250/72

摘要： Disclosed is a composition comprising MZ for use as a dietary supplement or food additive for oral consumption for improving the visual performance of a human subject.

公开(公告)号：US09462821B2

公开(公告)日：2016-10-11

申请号：US13133295

申请日：2009-11-23

申请人： Marie-Claire Fichot ,  Catherine Mace ,  Philippe Steenhout

发明人： Marie-Claire Fichot ,  Catherine Mace ,  Philippe Steenhout

IPC分类号： A23C9/00 ,  A23L1/29 ,  A23L1/30 ,  A23L1/302 ,  A23L1/304 ,  A23L1/305

CPC分类号： A23L33/40 ,  A23L33/12 ,  A23L33/15 ,  A23L33/16 ,  A23L33/17 ,  A23L33/18 ,  A23V2002/00 ,  A23V2200/30 ,  A23V2250/1868

摘要： A method of reducing the accumulation of fat mass in a neonatal human infant at risk thereof which method comprises administering to the infant during at least a part of the neonatal period a therapeutic amount of a nutritional composition comprising proteins in an amount such that the composition contains more than 2.4 g of protein per 100 kcal. As weight gain during the first week of life has been associated with overweight in adulthood, this may offer a method of reducing the risk of developing obesity in later life. Also claimed is the administration of DHA to the mother during gestation period.

摘要翻译： 一种减少在危险中的新生儿人的婴儿中脂肪积累的方法，包括在新生儿期的至少一部分期间向婴儿施用治疗量的营养组合物，其含有使得该组合物含有的量的蛋白质 每100千卡超过2.4克蛋白质。 由于生命第一周的体重增加与成人超重有关，因此可能会提供一种降低晚期发生肥胖风险的方法。 还声称是在妊娠期间对母亲进行DHA的管理。

公开(公告)号：US09446137B2

公开(公告)日：2016-09-20

申请号：US14591514

申请日：2015-01-07

申请人： ASAHI KASEI CHEMICALS CORPORATION

发明人： Takumi Magome ,  Kazuhiro Obae

IPC分类号： B32B5/16 ,  B32B5/18 ,  A61K47/38 ,  C08J3/12 ,  C08L1/02 ,  A61K47/02 ,  A61K31/355 ,  C08K3/34 ,  A23L1/304 ,  A61K9/14 ,  A61K47/36 ,  A61K9/20 ,  A23L1/00

CPC分类号： A61K47/38 ,  A23L5/00 ,  A23L29/30 ,  A23L33/125 ,  A23L33/16 ,  A23P10/22 ,  A23P10/40 ,  A23V2002/00 ,  A61K9/14 ,  A61K9/2009 ,  A61K9/2054 ,  A61K31/355 ,  A61K47/02 ,  A61K47/36 ,  C08J3/122 ,  C08J2301/02 ,  C08K3/34 ,  C08L1/02 ,  Y10T428/249958 ,  Y10T428/24999 ,  Y10T428/2982 ,  Y10T428/2991 ,  Y10T428/2998 ,  Y10T428/31971

摘要： Provided are composite particles which exhibit excellent fluidity and high liquid retentivity and which exhibit high fluidity even in a liquid-holding state. Also provided are composite particles which permit direct compressing in an open feed manner and which suffer from little compressing trouble and exhibit high shapability. When shaped together with an active ingredient, the composite particles provide shaped bodies which have uniform weight, uniform active ingredient content, and high hardness and which suffer from less galling.

摘要翻译： 提供了表现出优异的流动性和高液体保持性并且即使在液体保持状态下也表现出高流动性的复合颗粒。 还提供了允许以开放进料方式直接压缩并且几乎没有压缩故障并且表现出高成型性的复合颗粒。 当与活性成分一起成型时，复合颗粒提供具有均匀重量，均匀的活性成分含量和高硬度并且具有较少磨损的成形体。

公开(公告)号：US09446128B2

公开(公告)日：2016-09-20

申请号：US12398865

申请日：2009-03-05

申请人： Eun A Choi

发明人： Eun A Choi

IPC分类号： A61K33/34 ,  A61K45/06 ,  A23L1/304

CPC分类号： A61K45/06 ,  A23L33/16 ,  A23V2002/00 ,  A61K33/34 ,  A61K2300/00 ,  A23V2250/1588 ,  A23V2200/308

摘要： The present invention relates to a composition comprising an egg white combined chalcanthite component for preventing or treating cancer, and more particularly, to a composition for preventing or treating cancer, which comprises egg white combined chalcanthite prepared by mixing a roasted chalcanthite with egg white to reduce the toxicity of the chalcanthite or comprises a mixture of the egg white combined chalcanthite and a bamboo salt, and a method for preparing the same. The composition comprising the egg white combined chalcanthite exhibits excellent anti-cancer activity, and thus is usefully applicable to pharmaceutical preparations for preventing or treating cancer or the manufacture of health functional foods.

摘要翻译： 本发明涉及一种包含用于预防或治疗癌症的蛋白组合的硫铁矿成分的组合物，更具体地，涉及用于预防或治疗癌症的组合物，其包含通过将焙烤的赤铁矿与蛋清混合而制备的蛋白组合的赤铁矿，以减少 黄铁矿的毒性或由蛋白组合的赤铁矿和竹盐的混合物及其制备方法。 包含蛋白组合的赤铁矿的组合物表现出优异的抗癌活性，因此可用于预防或治疗癌症的药物制剂或健康功能性食品的制造。

公开(公告)号：US09414619B2

公开(公告)日：2016-08-16

申请号：US14616527

申请日：2015-02-06

申请人： Cambrooke Therapeutics, Inc.

发明人： Charles E. Sizer ,  Leah Alea ,  Kurt Olson

IPC分类号： A23L1/305 ,  A23L1/29 ,  A23L1/302 ,  A23L1/303 ,  A23L1/304

CPC分类号： A23L33/40 ,  A23L33/15 ,  A23L33/155 ,  A23L33/16 ,  A23L33/175 ,  A23V2002/00

摘要： This is a process to make a shelf-stable, liquid, ready-to-drink, aseptic nutritional formula for the treatment of PKU, tyrosinemia or other errors of metabolism. The liquid nutritional formula has caseino-glyco-macropeptide as the primary protein source and complementary essential amino acids to complete the requirement profile. The beverage also includes vitamins and minerals sufficient to meet daily requirements. When used as a complete diet, the nutritional formula includes a carbohydrate source and a fat source. The nutritional formula has a pleasant taste.

摘要翻译： 这是一种制备稳定，液体，即食饮料，无菌营养配方用于治疗PKU，酪氨酸血症或其他新陈代谢错误的过程。 液体营养配方具有酪蛋白糖多糖作为主要蛋白质来源和互补必需氨基酸，以完成需求分布。 饮料还包括足以满足日常需求的维生素和矿物质。 当用作完整的饮食时，营养配方包括碳水化合物来源和脂肪来源。 营养配方味道宜人。

公开(公告)号：US09414599B2

公开(公告)日：2016-08-16

申请号：US14124222

申请日：2012-06-07

申请人： Giuliano Leonardi

发明人： Giuliano Leonardi

IPC分类号： A01N55/02 ,  B01J31/04 ,  A61K31/60 ,  A01N59/16 ,  A01N59/20 ,  A61K33/26 ,  A61K33/30 ,  A61K33/32 ,  A61K33/34 ,  A61K33/36 ,  A61K33/38 ,  A61K45/06 ,  A61K33/24 ,  A61K8/368 ,  A61Q5/02 ,  A61Q11/00 ,  A61Q19/10 ,  A61K8/92 ,  A23L1/304 ,  A23K1/16 ,  A23K1/175 ,  A23K1/18 ,  A23L1/30 ,  A23D9/007 ,  A23K1/00

CPC分类号： A01N55/02 ,  A01N59/16 ,  A01N59/20 ,  A23D9/007 ,  A23K20/111 ,  A23K20/22 ,  A23K20/24 ,  A23K20/30 ,  A23K40/10 ,  A23K50/10 ,  A23L33/10 ,  A23L33/16 ,  A61K8/368 ,  A61K8/922 ,  A61K31/60 ,  A61K33/24 ,  A61K33/26 ,  A61K33/30 ,  A61K33/32 ,  A61K33/34 ,  A61K33/36 ,  A61K33/38 ,  A61K45/06 ,  A61Q5/02 ,  A61Q11/00 ,  A61Q19/10 ,  B01J31/04 ,  A01N37/40 ,  A01N2300/00 ,  A61K2300/00

摘要： A process is described for the preparation of a composition comprising a metal complex in an oily organic matrix, the latter being at the same time able to promote the formation of the complex. Said process also envisages that the complex, once formed, is not separated from said oily organic matrix, but the resulting composition is used as such, as having observed that the performances of the complex present therein is thus improved.

摘要翻译： 描述了一种用于制备包含油性有机基质中的金属络合物的组合物的方法，后者同时能够促进络合物的形成。 所述方法还设想，一旦形成的络合物不与所述油性有机基质分离，但是所得组合物原样使用，因为观察到其中存在的络合物的性能得到改善。